| Nazwa produktu: |
erythromycin estolate |
| Angielska nazwa |
erythromycin estolate; Erythromycin estolate [USAN:BAN:JAN]; Biomicron; Eriscel; Eritroger; Eromycin; Ery-Toxinal dodecylsulfate; Erythromycin 2'-propionate dodecyl sulfate (salt); Erythromycin 5-(3-propionate) dodecyl sulfate; Erythromycin propionate dodecylsulfate (salt); Erythromycin propionate lauryl sulfate; Erythromycin propionate, compd. with dodecyl sulfate; Erythromycin propionate, compound with dodecyl sulfate; Erythromycin propionyl laurylsulfate; Erythromycin, propionate (ester), compd. with monododecyl sulfate; Erythromycine estolate; Erytrarco; Estomicina; Ilosone; Lauromicina; Lauryl sulfate propionyl erythromycin ester; Lubomycine B; Marcoeritrex; NSC 263364; Neo-erycinum; PELS; Propionic acid, 2'-ester with erythromycin, dodecyl sulfate salt; Propionylerythromycin lauryl sulfate; Prospiocine; Roxomicina; Stellamicina; Sulfuric acid, monododecyl ester, compd. with erythromycin 2'-propionate (1:1); UNII-XRJ2P631HP; Erythromycin, 2'-propanoate, dodecyl sulfate (salt); Erythromycin, 2'-propionate, monododecyl sulfate (salt) (8CI); Erythromycin, propionate (ester), compd. with monododecyl sulfate (1:1); Sulfuric acid, monododecyl ester, compd. with erythromycin 2'-propanoate (1:1); 4-(dimethylamino)-2-({(3R,4S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy]-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl}oxy)-6-methyltetrahydro-2H-pyran-3-yl propanoate - dodecyl hydrogen sulfate (1:1) (non-preferred name); 4-(dimethylamino)-2-({14-ethyl-7,12,13-trihydroxy-4-[(5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy]-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl}oxy)-6-methyltetrahydro-2H-pyran-3-yl propanoate - dodecyl hydrogen sulfate (1:1) (non-preferred name); 2-({(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy]-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl}oxy)-N,N,6-trimethyl-3-(propanoyloxy)tetrahydro-2H-pyran-4-aminium dodecyl sulfate (non-preferred name); Erythromycin 2'-Propionate Dodecyl Sulfate |
| MF |
C52H97NO18S |
| Masie cząsteczkowej |
1056.3875 |
| InChI |
InChI=1/C40H71NO14.C12H26O4S/c1-15-27-40(11,48)33(44)22(5)30(43)20(3)18-38(9,47)35(55-37-32(53-28(42)16-2)26(41(12)13)17-21(4)50-37)23(6)31(24(7)36(46)52-27)54-29-19-39(10,49-14)34(45)25(8)51-29;1-2-3-4-5-6-7-8-9-10-11-12-16-17(13,14)15/h20-27,29,31-35,37,44-45,47-48H,15-19H2,1-14H3;2-12H2,1H3,(H,13,14,15)/t20-,21?,22+,23+,24-,25?,26?,27-,29?,31+,32?,33-,34?,35-,37?,38-,39?,40-;/m1./s1 |
| Nr CAS |
3521-62-8 |
| EINECS |
222-532-4 |
| Struktury molekularnej |
|
| Temperatura wrzenia |
827.7°C at 760 mmHg |
| Temperatura zapłonu |
454.4°C |
| Ciśnienie pary |
8.87E-32mmHg at 25°C |
| Symbole zagrożenia |
 Xn:Harmful;
|
| Kody ryzyka |
R22:;
R42/43:;
|
| Bezpieczeństwo opis |
S22:;
S36:;
|
|
